Home LiteratureArticle Details
PMID: 2572788 Published · ppublish English Letter

Urokinase-type plasminogen activator antigen and early relapse in breast cancer.

Lancet (London, England) ·Vol. 2 ·No. 8670 ·1989-10-28 ·Pages 1049

Jänicke F, Schmitt M, Ulm K, Gössner W, Graeff H

Abstract

暂无摘要

MeSH Terms
Antigens/analysis Breast Neoplasms/enzymology Female Fibrinolytic Agents/immunology Humans Neoplasm Recurrence, Local/enzymology Plasminogen Activators/immunology Prognosis Urokinase-Type Plasminogen Activator/immunology
Chemicals
Antigens Fibrinolytic Agents Plasminogen Activators Urokinase-Type Plasminogen Activator
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Jänicke F
Schmitt M
Ulm K
Gössner W
Graeff H
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/s0140-6736(89)91070-2
Published
1989-10-28
Pages
1049
Language
English
Region
England
NLM ID
2985213R
Subset
IM
External Links
PubMed source DOI: 10.1016/s0140-6736(89)91070-2 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2